Intervention Based on the Mediterranean Diet During Pregnancy and the First Two Years for the Improvement of Neurological Development
CONMED
Randomized Controlled Clinical Trial: Dietetic-nutritional Intervention Based on the Mediterranean Diet During Pregnancy and the First Two Years, First Thousand Days, for the Improvement of Neurological Development
2 other identifiers
interventional
534
0 countries
N/A
Brief Summary
The main objective is to evaluate the effect of the Mediterranean diet during pregnancy and the first two years of the child\'s life on the child\'s neurodevelopment and behavior (externalizing and internalizing disorders) measured at one and a half and two years. Secondary objectives are to evaluate the effect of the Mediterranean diet on: body composition at two years of age in infants (densitometry) and of the mother at 3 months postpartum, the incidence of allergic disease in infants, the fetal and infant ́s growth and metabolic risk in the mother during pregnancy and in the boy/girl at two years (fasting glucose: insulin, HOMA), LDL and HDL cholesterol, and micronutrient status (iron, calcium, phosphorus, magnesium, sodium, potassium, chloride, selenium, zinc and LCPUFAs). Randomized controlled clinical trial with a 1:1 ratio, parallel and open label. Group 1: Mother-child binomial with nutritional intervention; Group 2: Mother-child binomial as a control group (with follow-up without intervention). Assuming a loss of 25% (10% at follow-up, 15% failure of nutritional intervention) we would need a sample size of 267 patients per group. 1. Evaluation of neurodevelopment using the Bayleys scale version -III, at 2 years of age. 2. Behavioral assessment CBCL at 1.5 and two years and BRIEF-P at two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
September 26, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
September 26, 2024
September 1, 2024
4.3 years
September 19, 2024
September 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Neurodevelopmental assessment an behavior at 2 years old
Neurodevelopmental assessment using the Bayleys scale version III
Assessment at 2 years of age
Study Arms (2)
Mother-child binomial with nutritional intervention
ACTIVE COMPARATORInterventions will be based on dietary-nutritional advice, derived from scientific evidence: nutrition based on the Mediterranean diet (MD) and usual treatment
Mother-child binomial as a control group (with follow-up without intervention).
PLACEBO COMPARATORMother-child binomial as a control group, with follow-up without intervention.
Interventions
Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age
Eligibility Criteria
You may qualify if:
- a. Fluency in the Spanish language, singleton pregnancy
You may not qualify if:
- Children conceived with assisted reproduction techniques
- Fetal anomalies and congenital infections
- Neonatal anomalies diagnosed after birth
- Intellectual development disorder, due to clinical judgment, inability to attend visits
- Participation in another controlled trial
- Vegetarian diet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Miguel Saenz de Pipaon Marcos, Professor
HOspital La Paz Institute for Health Research
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatrician; Neonatologist
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 26, 2024
Study Start
October 1, 2024
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
February 1, 2029
Last Updated
September 26, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
The intermediate and final data generated in the project will be uploaded to the most appropriate repositories depending on their typology and whenever possible for confidentiality issues and that does not hinder the protection of any possible intangible asset, provided that deal with Trustworthy Digital Repositories (Research Libraries Group, 2002) and follow the reference model OASIS, developed by the Consultative Committee for Space Data Systems (accredited by the ISO standard 14721:2012). In this way, these data, as well as the publications derived from the development of the project, will be deposited, among others, in the Institutional HEALTH REPository of the Carlos III Health Institute (REPISALUD, https://repisalud.isciii.es/), and in the Institutional Repository of the Ministry of Health of the Community of Madrid. Access for other researchers who may be legitimately interested will be subject in any case to their approval, complying with the requirement of open access